Condition: Mast Cell Disorder · Sponsor: Imagine Institute
Mast cell disorders constitute a heterogeneous group of diseases, including : * mastocytosis, i.e. cutaneous, indolent and severe forms of the disease, such as aggressive mastocytosis and mast cell leukemia) ; * mast cell-associated diseases such as mast cell activation syndrome (idiopathic, secondary or clonal), affecting both children and adults. No epidemiological data are currently available in France. In France, medical care of mast cell disorders is mainly provided by a rare disease network (CEREMAST), whose CRMR is located at the Necker Enfants Malades hospital in Paris. A total of 20 centers are located throughout France. Our aim is to use this network to study patients suffering from these diseases. The overall aim of the study is to improve the understanding, diagnosis, prognosis, recognition and management of patients with mastocytosis.
This description comes directly from the study's public registry record.
Julien Rossignol, Dr · +33 (0)1 44 49 40 00 · julien.rossignol@aphp.fr
Always discuss trial participation with your own doctor first.
| CHU AMIENS site sud | Amiens, France | Recruiting |
| Chu Angers | Angers, France | Recruiting |
| Chu - Besancon | Besançon, France | Recruiting |
| Chu - Caen | Caen, France | Recruiting |
| Chu - Clermont Ferrand | Clermont-Ferrand, France | Recruiting |
| CHU Grenoble | Grenoble, France | Recruiting |
| Chru Lille | Lille, France | Recruiting |
| Chu - Limoges | Limoges, France | Recruiting |
| Hospices Civils de Lyon | Lyon, France | Recruiting |
| Chu - La Timone - Marseille | Marseille, France | Recruiting |
| CHU de Montpellier | Montpellier, France | Recruiting |
| CHU de NANCY | Nancy, France | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06186856